Binita Shah Ashar MD , MBA, FACS, MAMSE
Director, Office of Surgical and Infection Control Devices US FDA
Join to View Full Profile
10903 New Hampshire AveHfz-410Silver Spring, MD 20993
Phone+1 301-796-6385
Dr. Ashar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Binita Ashar is a general surgeon based in Silver Spring, MD. She completed her surgery residency at Cleveland Clinic Foundation in 1998 after graduating from Ohio State University College of Medicine in 1993. She has contributed significantly to the field through her publications, including works on breast implant-associated anaplastic large-cell lymphoma, which have been widely cited in renowned journals. Dr. Ashar is recognized as a Fellow of the American College of Surgeons.
Education & Training
Cleveland Clinic FoundationResidency, Surgery, 1993 - 1998
Ohio State University College of MedicineClass of 1993
Certifications & Licensure
MD State Medical License 1998 - 2025
VA State Medical License 2013 - 2024
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- Commentary on: US FDA Patient Decision Checklist for Breast Implants: Results of a Survey to Members of The Aesthetic Society, April 2022.Binita S Ashar
Aesthetic Surgery Journal. 2023-02-03 - 49 citationsBest Practices Guideline for the Pathologic Diagnosis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.Elaine S. Jaffe, Binita S. Ashar, Mark W. Clemens, Andrew L. Feldman, Philippe Gaulard
Journal of Clinical Oncology. 2020-02-11 - Breast Implant-Associated Anaplastic Large Cell Lymphoma.Binita S. Ashar, Sung W. Yoon, Steven Nagel
American Family Physician. 2020-01-01
Press Mentions
FDA Orders New Restrictions, Stronger Warnings for Breast ImplantsOctober 28th, 2021- Health Highlights: April 1, 2021April 1st, 2021
- FDA Authorizes First Surgical Robot to Help with Transvaginal HysterectomiesMarch 1st, 2021
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
